BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Diagnosis
372 results:

  • 1. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 2. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
    Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
    Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical features and mutation analysis of class 1/2/3 braf mutation colorectal cancer.
    Huang Y; Jia W; Zhao G; Zhao Y; Zhang S; Li Z; Wu G
    Chin Clin Oncol; 2024 Feb; 13(1):3. PubMed ID: 38372057
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur).
    Hitchcock KE; Miller ED; Shi Q; Dixon JG; Gholami S; White SB; Wu C; Goulet CC; George M; Jee KW; Wright CL; Yaeger R; Shergill A; Hong TS; George TJ; O'Reilly EM; Meyerhardt JA; Romesser PB
    BMC Cancer; 2024 Feb; 24(1):201. PubMed ID: 38350888
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Exploring the role of sporadic braf and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
    Tang J; Lam GT; Brooks RD; Miles M; Useckaite Z; Johnson IR; Ung BS; Martini C; Karageorgos L; Hickey SM; Selemidis S; Hopkins AM; Rowland A; Vather R; O'Leary JJ; Brooks DA; Caruso MC; Logan JM
    Cancer Lett; 2024 Mar; 585():216639. PubMed ID: 38290660
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. United States-Based colorectal cancer Surgical Trials Lack Representation and Adequate Reporting of Racially and Ethnically Diverse Participants: Systematic Review and Regression Analysis.
    Ore AS; Areán-Sanz R; Liu BS; Arndt KR; Hernandez Alvarez A; Ponce CJ; Bain PA; Messaris E
    Dis Colon Rectum; 2024 May; 67(5):624-633. PubMed ID: 38276952
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in
    Tsai HL; Huang CW; Chen YC; Su WC; Chang TK; Chen PJ; Li CC; Chang YT; Wang JY
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138211
    [No Abstract]    [Full Text] [Related]  

  • 8. High-Fidelity Identification of Single Nucleotide Polymorphism by Type V CRISPR Systems.
    He Y; Shao S; Chen J
    ACS Sens; 2023 Dec; 8(12):4478-4483. PubMed ID: 38010835
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Serrated colorectal cancer: preclinical models and molecular pathways.
    Aiderus A; Barker N; Tergaonkar V
    Trends Cancer; 2024 Jan; 10(1):76-91. PubMed ID: 37880007
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An incidental traditional serrated adenoma of the gallbladder: A case report.
    Abecia Martínez EI; Ríos Ballestín G; Castillo Malla J; Martínez Arnau N; Hörndler Argarate C
    Rev Esp Patol; 2023; 56(4):271-274. PubMed ID: 37879824
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review.
    Ribeiro LM; Bomtempo FF; Rocha RB; Telles JPM; Neto EB; Figueiredo EG
    Clin Exp Metastasis; 2023 Dec; 40(6):445-463. PubMed ID: 37819546
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. EARLY-ONSET colorectal cancer: AN ELEVEN-YEAR ANALYSIS OF CLINICOPATHOLOGICAL CHARACTERISTICS AT A TERTIARY HEALTHCARE CENTER.
    Piñerúa-Gonsálvez JF; Zambrano-Infantino RDC; Rizzo-Rodríguez MA; Dueñas-Diez A; Fernández-Salazar L
    Arq Gastroenterol; 2023; 60(3):315-321. PubMed ID: 37792760
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.
    Lawler T; Parlato L; Warren Andersen S
    Cancer Causes Control; 2024 Feb; 35(2):223-239. PubMed ID: 37688643
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis.
    Magnusson MI; Agnarsson BA; Jonasson JG; Tryggvason T; Aeffner F; le Roux L; Magnusdottir DN; Gunnarsdottir HS; Alexíusdóttir KK; Gunnarsdottir K; Söebech E; Runarsdottir H; Jonsdottir EM; Kristinsdottir BS; Olafsson S; Knutsdottir H; Thorsteinsdottir U; Ulfarsson MO; Gudbjartsson DF; Saemundsdottir J; Magnusson OT; Norddahl GL; Watson JEV; Rafnar T; Lund SH; Stefansson K
    Br J Cancer; 2023 Oct; 129(7):1142-1151. PubMed ID: 37596405
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hilar/mediastinal and cutaneous drug-induced sarcoidosis-like reaction associated with immune checkpoint inhibitors in metastatic colorectal cancer: a case report.
    Sagawa T; Sato Y; Nagashima H; Takada K; Takahashi M; Hirakawa M; Hamaguchi K; Tamura F; Fujikawa K; Okamoto K; Kawano Y; Sogabe M; Miyamoto H; Takayama T
    Front Immunol; 2023; 14():1203621. PubMed ID: 37492584
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Constitutional MLH1 Methylation Is a Major Contributor to Mismatch Repair-Deficient, MLH1-Methylated colorectal cancer in Patients Aged 55 Years and Younger.
    Hitchins MP; Dámaso E; Alvarez R; Zhou L; Hu Y; Diniz MA; Pineda M; Capella G; Pearlman R; Hampel H
    J Natl Compr Canc Netw; 2023 Jul; 21(7):743-752.e11. PubMed ID: 37433431
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study.
    Bachet JB; Laurent-Puig P; Meurisse A; Bouché O; Mas L; Taly V; Cohen R; Gornet JM; Artru P; Louafi S; Thirot-Bidault A; Baumgaertner I; Coriat R; Tougeron D; Lecomte T; Mary F; Aparicio T; Marthey L; Blons H; Vernerey D; Taieb J
    Eur J Cancer; 2023 Aug; 189():112934. PubMed ID: 37390800
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique.
    Liu K; Cui Y; Li H; Mi J; Wang H; Zhuang Y; Tang L; Liu J; Tian C; Zhang Z; Zhou J; Shi H; Tian X; Liu P
    Crit Rev Oncol Hematol; 2023 Aug; 188():104057. PubMed ID: 37328085
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil.
    Koper A; Wileński S; Śledzińska P; Bebyn M; Koper K
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10867-10877. PubMed ID: 37318592
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiomics in colorectal cancer patients.
    Inchingolo R; Maino C; Cannella R; Vernuccio F; Cortese F; Dezio M; Pisani AR; Giandola T; Gatti M; Giannini V; Ippolito D; Faletti R
    World J Gastroenterol; 2023 May; 29(19):2888-2904. PubMed ID: 37274803
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.